相关实验视频
Updated: Sep 10, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
通过间歇性血糖监测在患有1型糖尿病的儿童中不同胰岛素使用模式之间的代谢控制差异
Rocio Porcel-Chacón1, Leopoldo Tapia-Ceballos2,3, Ana-Belen Ariza-Jimenez4,5,6
1Universitary Costa del Sol Hospital A-7, Km 187, 29603 Málaga, Spain.
Diseases (Basel, Switzerland)
|August 27, 2025
概括
与每日多次注射 (MDI) 相比,间歇性用胰岛素 (CSII) 监测儿童1型糖尿病患者的代谢控制. 然而,范围内的时间目标并未始终实现,这表明要仔细考虑启动CSII.
科学领域:
- 内分泌学
- 儿童糖尿病管理
- 医疗技术
背景情况:
- 使用胰岛素间歇性血糖监测 (isCGM) 为资源有限的环境或自我管理的治疗调整提供了替代方案.
- 这种方法需要进一步研究,特别是在1型糖尿病的儿童患者中.
研究的目的:
- 在儿童1型糖尿病患者中,评估isCGM与连续皮下胰岛素输注 (CSII) 与每日多次注射 (MDI) 的有效性.
- 在CSII和MDI组之间比较代谢控制参数,包括时间范围 (TIR) 和HbA1c.
主要方法:
- 一个前性,单中心研究,涉及1型糖尿病儿童患者.
- 数据收集发生在isCGM植入后3个月和1年,患者按胰岛素治疗方案 (CSII与MDI) 分类.
主要成果:
- 与MDI相比,CSII在更严格的TIR (70-140 mg/dl) 中在3个月和1年内显示出统计学上显著的改善.
- 一年后,75%的CSII患者达到HbA1c< 7%,而MDI组的这一比例为34. 6%.
- 在CSII组中,变化系数较高,低血糖发作较多,最初每日血糖测量较高.
结论:
- 在使用isCGM一年后,CSII在儿童1型糖尿病中比MDI具有优越的代谢控制.
- 尽管情况有所改善,但TIR价值仍低于最佳控制范围,这促使人们讨论了CSII的最佳时间和整合.
- 这些发现表明CSII在特定场景或被集成到闭环系统中可能是有益的.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
257
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
257
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Insulin Formulations: Types and Delivery
270
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
270
Diabetes: Management and Pharmacotherapy
362
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
362
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K

